Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical concern for antibiotic resistance]

S. Esposito1

  • 1Clinica Malattie Infettive, Seconda Universita degli Studi di Napoli, Italy.

Le Infezioni in Medicina
|May 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Streptogramins: Educational Network]

Le infezioni in medicina·2003
Same author

[Health and war]

Le infezioni in medicina·2003
Same author

[Microbiological survey in an Intensive Care Unit]

Le infezioni in medicina·2003
Same author

[Public health and politics]

Le infezioni in medicina·2003
Same author

21st International Congress of Chemotherapy in Birmingham.

Le infezioni in medicina·2003
Same author

[Scientific research and scientific journals]

Le infezioni in medicina·2003
Same journal

Rezafungin and catheter-related candidemia: a new player in a high-stakes game.

Le infezioni in medicina·2026
Same journal

Effectiveness and Safety Profile of BIC/TAF/FTC in People living with HIV Switched from Other Antiretroviral Regimens: A Real-Life Retrospective Cohort Analysis.

Le infezioni in medicina·2026
Same journal

Insights into parvovirus B19 clinical and virological dynamics among blood donors.

Le infezioni in medicina·2026
Same journal

When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship.

Le infezioni in medicina·2026
Same journal

Fragility of Immunisation and Water Systems in Gaza: Infectious Disease Risks in a Conflict-Affected Setting.

Le infezioni in medicina·2026
Same journal

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
See all related articles

Antibiotic resistance is a major threat, leading to treatment failures and increased mortality. Combating this requires understanding resistance mechanisms, tracking spread, and developing new drugs, alongside improved antibiotic use and guidelines.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance poses a severe global health threat, potentially leading to a post-antibiotic era.
  • It significantly increases treatment failures, morbidity, mortality rates, and healthcare costs.
  • Key priority pathogens include Mycobacterium tuberculosis, Streptococcus pneumoniae, Staphylococcus spp., Enterococcus spp., and Neisseria gonorrhoeae.

Purpose of the Study:

  • To outline current strategies for combating antibiotic resistance.
  • To highlight the importance of both therapeutic and preventive interventions.
  • To emphasize the need for a multi-faceted approach involving scientific research and clinical practice.

Main Methods:

  • Identification of bacterial resistance mechanisms.

Related Experiment Videos

  • Conducting epidemiological surveys to track resistance patterns.
  • Synthesizing novel antimicrobial agents effective against resistant microorganisms.
  • Main Results:

    • Three primary approaches identified: understanding resistance, epidemiological surveillance, and new drug development.
    • Preventive interventions are crucial, including optimizing prophylaxis and therapy duration.
    • Improving antibiotic prescribing through education, monitoring, and guidelines is essential.

    Conclusions:

    • A comprehensive strategy is needed to combat antibiotic resistance.
    • This strategy must integrate research into resistance mechanisms and new drug discovery with improved clinical practices.
    • Effective control requires international collaboration and the implementation of evidence-based guidelines.